Can We Ask ChatGPT About Drug Safety? Appropriateness of ChatGPT Responses to Questions About Drug Use and Adverse Reactions Received by Pharmacovigilance Centers

Journal article

Peer reviewed

Antoine Pariente, Francesco Salvo, Virginie Bres and Jean-Luc Faillie

Drug Safety, Vol.47, pp.921-923

08/05/2024

PMID: 38717670

Abstract

ChatGPT

Pharmacovigilance

Drug use

Drug adverse effects

Adverse Drug Reaction Reporting Systems

Drug-Related Side Effects and Adverse Reactions*

Humans

Pharmacovigilance*

url

Find in HALView

1 Record Views

Title: Can We Ask ChatGPT About Drug Safety? Appropriateness of ChatGPT Responses to Questions About Drug Use and Adverse Reactions Received by Pharmacovigilance Centers
Creators - without role: Antoine Pariente - Bordeaux Population Health
Francesco Salvo - Bordeaux Population Health
Virginie Bres - Département de Pharmacologie Médicale et de Toxicologie [CHRU Montpellier]
Jean-Luc Faillie - Institut Desbrest d'Epidémiologie et de Santé Publique
Publication Details: Drug Safety, Vol.47, pp.921-923
Identifiers: 9939131609311
Academic Unit: Institut Desbrest d Epidemiologie et de Sante Publique - IDESP
Language: English
Resource Type: Journal article
Local Fields: hal-04626252